15.2 Nonimmunologic Reactions

15.2 Nonimmunologic Reactions

Not every adverse effect of transfusion involves the recipient's immune system reacting to donor antigens or antibodies. Nonimmunologic reactions result from volume, physical, chemical, or metabolic effects of the transfused product itself, and — for chronically transfused patients — from the cumulative burden of the iron contained in every red cell unit.

Transfusion-Associated Circulatory Overload (TACO)

TACO develops when the volume and/or rate of transfusion exceeds the recipient's cardiovascular capacity to compensate, producing hydrostatic pulmonary edema. It has become one of the leading reported causes of transfusion-related death in recent hemovigilance data, often exceeding TRALI in frequency. Risk factors include preexisting cardiac or renal dysfunction, extremes of age (very young or elderly), positive fluid balance before transfusion, and rapid infusion of large volumes or multiple units without adequate spacing.

Onset is typically within 6 hours of transfusion (often within the first 1 to 2 hours) with dyspnea, orthopnea, tachycardia, hypertension, jugular venous distension, and bilateral infiltrates with cardiomegaly on chest imaging.

TACO vs. TRALI is a frequently tested distinction:

Prevention centers on slowing the infusion rate (commonly targeting no more than about 2 to 4 mL/kg/hour in high-risk patients rather than the standard rate used for healthy adults), transfusing one unit at a time with clinical reassessment between units, and premedicating high-risk patients with a diuretic. A pretransfusion risk assessment — reviewing cardiac and renal history, current fluid balance, and recent weight — identifies which patients need a slower rate or smaller-volume aliquots before the order is even placed, since TACO is largely preventable when risk is recognized in advance rather than treated only after symptoms appear.

Physical and Chemical Hemolysis (Nonimmune Hemolysis)

Red cells can be destroyed by nonimmune physical or chemical insults unrelated to any antibody:

• Thermal injury — freezing (inadequate temperature control during storage/transport) or overheating (blood warmer malfunction above roughly 42°C, or improper thawing) directly lyses red cells.
• Osmotic injury — infusing red cells through the same IV line as a hypotonic solution such as D5W or hypotonic saline causes water to rush into the cells and lyse them; only 0.9% normal saline is compatible for co-administration with blood components.
• Mechanical injury — forcing red cells through a small-bore needle, using a pressure infusion device or roller pump improperly, or excessive agitation can shear cell membranes.
• Improper additive/storage handling — using an incompatible IV additive solution, transfusing an expired unit, or exceeding the 4-hour hang-time limit once a unit is spiked can also contribute to hemolysis or bacterial risk.

These reactions can mimic an immune hemolytic reaction (hemoglobinemia, hemoglobinuria), so the standard workup — clerical check, DAT, and visual inspection — still applies to rule out an immune cause before attributing hemolysis to a physical/chemical mechanism.

Hypotensive Transfusion Reactions

A hypotensive transfusion reaction is an isolated, rapid drop in blood pressure occurring during or immediately after the start of transfusion, without fever, urticaria, or respiratory distress. The leading mechanism implicates bradykinin accumulation: negatively charged surfaces of bedside leukoreduction filters activate the contact (kallikrein-kinin) pathway, generating bradykinin, and patients taking ACE inhibitors are at particular risk because ACE (kininase II) normally degrades bradykinin, so inhibiting it allows bradykinin to accumulate further. Onset is typically within minutes of starting the transfusion, and blood pressure usually normalizes quickly once the transfusion is stopped. Because the presentation can resemble early anaphylaxis or septic shock, other reactions should be excluded, but the absence of skin, respiratory, and febrile findings favors a hypotensive reaction.

Iron Overload (Transfusional Hemosiderosis)

Chronic transfusion therapy — as used for thalassemia major, sickle cell disease, myelodysplastic syndromes, and some aplastic anemias — carries a long-term nonimmunologic hazard rather than an acute reaction. Each unit of red blood cells contains approximately 200 to 250 mg of iron, and the human body has no active physiologic mechanism to excrete excess iron. Over years of regular transfusion, iron accumulates first in the reticuloendothelial system and then in parenchymal organs — the liver, heart, and endocrine glands (pituitary, pancreas, gonads) — producing cirrhosis, cardiomyopathy (historically the leading cause of death in undertreated thalassemia major), diabetes mellitus, and hypogonadism.

Monitoring relies on serial serum ferritin, and, for more precise organ-specific iron burden, MRI-based techniques such as liver and cardiac T2* MRI, since ferritin alone can be affected by inflammation and does not always track true tissue iron concentration. Iron chelation therapy — with agents such as deferoxamine (parenteral, historically the standard but requiring slow subcutaneous or IV infusion over hours), deferasirox (oral, once daily), or deferiprone (oral, with better cardiac iron clearance in some studies but a risk of agranulocytosis requiring routine white blood cell count monitoring) — is typically initiated once ferritin rises above roughly 1,000 ng/mL or after a threshold number of transfused units, commonly cited around 10 to 20 units, and continued to prevent end-organ damage in patients who will require lifelong transfusion support.

Recognizing the Pattern on the Exam

Exam items on nonimmunologic reactions are frequently written as a paired comparison: a scenario is given, and the correct answer depends on identifying which single feature (blood pressure direction, presence or absence of fever, BNP result, response to a specific intervention, or the patient's medication list) rules a reaction in or out. TACO and TRALI are the most common pairing, but hypotensive reactions versus anaphylaxis (medication history and absence of skin/respiratory findings), and nonimmune versus immune hemolysis (a clean clerical check and negative DAT despite hemoglobinemia), follow the same testing pattern. Building the habit of asking what one differentiating feature is present transfers directly to the immunologic reactions covered in the previous section.